A comprehensive market investigation into the Gumitide counterfeit landscape reveals alarming patterns of brand exploitation, unauthorized distribution, and consumer safety risks across digital marketplaces in 2026.
A comprehensive market investigation into the Gumitide counterfeit landscape reveals alarming patterns of brand exploitation, unauthorized distribution, and consumer safety risks across digital marketplaces in 2026.
BANGKOK, June 4, 2026 /PRNewswire/ -- Delta Electronics (Thailand) Public Company Limited, a global leader in power management and smart green solutions, is presenting...
BOCA RATON, Fla., June 3, 2026 /PRNewswire/ - GardaWorld Cash announced it is seeking public assistance to help law enforcement apprehend the individuals responsible...
Langenfeld, Germany, June 03, 2026 (GLOBE NEWSWIRE) -- Booking Health today announced the release of findings examining international patient access to personalized dendritic cell therapy for glioblastoma in Germany. The findings, based on a documented Canadian patient case and supporting clinical research, highlight how cross-border treatment pathways may provide patients with aggressive brain tumors access to individualized immunotherapy options that are not widely available within all healthcare systems.
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Qiagen N.V. (“Qiagen” or the “Company”) (NYSE: QGEN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
BALA CYNWYD, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Positive Results from Phase 2a Clinical TrialStudy met its primary endpoint demonstrating safety and tolerability of ifetroban in patients with high-risk solid tumorsTrial revealed promising...
PMET's premier James Bay - Quebec geology delivers further exploration success with 2.94% Li2O, 16.43% Cs2O, and 3,768ppm Ta2O5 in surface samples at its...
PMET's premier James Bay - Quebec geology delivers further exploration success with 2.94% Li2O, 16.43% Cs2O, and 3,768ppm Ta2O5 in surface samples at its...
PMET's premier James Bay - Quebec geology delivers further exploration success with 2.94% Li2O, 16.43% Cs2O, and 3,768ppm Ta2O5 in surface samples at its...
NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Manhattan Associates, Inc. (NASDAQ: MANH).
NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Verra Mobility Corporation (“Verra Mobility” or the “Company”) (NASDAQ:VRRM) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.